Birzeit Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 2/6
Birzeit Pharmaceuticals is a dividend paying company with a current yield of 2.67% that is well covered by earnings.
Key information
2.7%
Dividend yield
-0.01%
Buyback Yield
| Total Shareholder Yield | 2.7% |
| Future Dividend Yield | n/a |
| Dividend Growth | -10.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$0.100 |
| Payout ratio | 67% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: BPC's dividend payments have been volatile in the past 10 years.
Growing Dividend: BPC's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Birzeit Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BPC) | 2.7% |
| Market Bottom 25% (PS) | 2.8% |
| Market Top 25% (PS) | 6.1% |
| Industry Average (Pharmaceuticals) | 1.8% |
| Analyst forecast (BPC) (up to 3 years) | n/a |
Notable Dividend: BPC's dividend (2.67%) isn’t notable compared to the bottom 25% of dividend payers in the PS market (2.77%).
High Dividend: BPC's dividend (2.67%) is low compared to the top 25% of dividend payers in the PS market (6.15%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (66.5%), BPC's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (98.2%), BPC's dividend payments are not well covered by cash flows.